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Egg reappearance periodAnthelmintics have been applied indiscriminately to control horse nematodes for over 40 years. Three
broad-spectrum anthelmintic classes are currently registered for nematode control in horses: benzimi-
dazoles (fenbendazole, oxibendazole), tetrahydropyrimidines (pyrantel) and macrocyclic lactones (iver-
mectin, moxidectin). Generally, control strategies have focused on nematode egg suppression regimens
that involve the frequent application of anthelmintics to all horses at intervals based on strongyle egg
reappearance periods after treatment. The widespread use of such programmes has substantially reduced
clinical disease, especially that associated with large strongyle species; however, high treatment fre-
quency has led to considerable selection pressure for anthelmintic resistance, particularly in cyathosto-
min species. Field studies published over the last decade indicate that benzimidazole resistance is
widespread globally in cyathostomins and there are also many reports of resistance to pyrantel in these
worms. Cyathostomin resistance to macrocyclic lactone compounds is emerging, principally measured as
a reduction in strongyle egg reappearance time observed after treatment. Ivermectin resistance is a fur-
ther concern in the small intestinal nematode, Parascaris equorum, an important pathogen of foals. These
issues indicate that horse nematodes must now be controlled using methods less dependent on anthel-
mintic use and more reliant on management practices designed to reduce the force of infection in the
environment. Such strategies include improved grazing management integrated with targeted anthel-
mintic administration involving faecal egg count (FEC)-directed treatments. The latter require that the
supporting diagnostic tests available are robust and practically applicable. Recent research has focused
on maximising the value of FEC analysis in horses and on optimizing protocols for anthelmintic efﬁcacy
testing. Other studies have sought to develop diagnostics that will help deﬁne levels of pre-patent infec-
tion. This review describes recent advances in each of these areas of research.
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Horses worldwide are exposed to an array of gastrointestinal
nematodes. Animals that graze contaminated pasture, and which
are not treated with effective anthelmintics, can accumulate large
numbers of worms. The most prevalent of these are members of
the small strongyle group, the cyathostomins (Ogbourne, 1976;
Bucknell et al., 1995; Gawor, 1995; Kuz’mina, 2012; Relf et al.,
2013). When the total burden of cyathostomins is high, they can
seriously compromise the health of affected individuals (Mair,
1994; Matthews, 2008; Matthews, 2008, 2014). Substantial bur-
dens (i.e. several million) of immature cyathostomins can encyst
in the large intestinal wall and it is thought that these stages can
persist for years (Murphy and Love, 1997). These stages, in partic-
ular early third stage larvae (EL3), are relatively insensitive to most
anthelmintics available (Monahan et al., 1996). In temperate areas
of the northern hemisphere, cyathostomin larvae encyst primarily
during the autumn and winter and can comprise up to 90% of the
total burden (Dowdall et al., 2002). When these larvae re-emerge
in large numbers from the gut wall, a fatal colitis, larval cyatho-
stominosis, can develop (Giles et al., 1985).
Several other nematode species infect horses and other equids,
but the prevalence of these species is usually lower than that of
cyathostomins (Relf et al., 2013). The most important non-
cyathostomin species affecting horses older than one year is
Strongylus vulgaris. This nematode can cause non-strangulating
intestinal infarction leading to severe colic and was the major par-
asitic threat to equine health before the advent of broad-spectrum
anthelmintics, in particular, the macrocyclic lactones (Reinemeyer
and Nielsen, 2009). In younger horses (i.e. those less than
2 years-old), the small intestinal ascarid, Parascaris equorum, can
be a substantial risk, producing both respiratory and intestinal
signs of disease (Cribb et al., 2006). The lungworm, Dictyocaulus
arnﬁeldi (MacKay and Urquhart, 1979), and the liver ﬂuke, Fasciola
hepatica (Owen, 1977), can undergo life cycle development in
horses and lead to clinical signs; these are a particular hazard in
horses that co-graze with, or graze pastures recently populated
by, more permissive hosts such as donkeys and ruminants, respec-
tively. There are few published studies describing the factors that
affect the prevalence and abundance of the various parasitic nem-
atode species of horses. A recent publication identiﬁed that a lack
of rotational grazing practices (between age groups or host spe-
cies) was associated with a higher prevalence of cyathostomin
egg excretion on Thoroughbred stud farms (Relf et al., 2013). In
the same study, higher levels of strongyle egg shedding (i.e. >200
eggs per gram) in faeces were observed to be signiﬁcantly associ-
ated with a number of factors, with a recent history of treatment
with fenbendazole identiﬁed as the most signiﬁcant factor. The lat-
ter observation may be linked to the fact that there is a high prev-
alence of benzimidazole resistance in cyathostomin populations
(see below).
Since the 1960s, nematode control has followed interval treat-
ment regimens involving the frequent administration of anthel-
mintic products at intervals based on strongyle egg reappearance
periods (ERP). These periods were deﬁned for each chemical class
of compound at the time of licensing (Parry et al., 1993; Kaplan
and Nielsen, 2010). Such interval treatment programmes have
been successful in substantially reducing the prevalence of stron-
gyle infections and the incidence of large strongyle-associated dis-
ease. On the ﬂip side, these programmes have made a substantial
contribution to the development of anthelmintic resistance, partic-
ularly in cyathostomin species (Kaplan, 2004). Should anthelmintic
resistance levels worsen, there will be limited scope for control, as
no new classes of compound appear to be under development for
use in horses in the short to medium term. Based on comparativestudies on sheep nematodes (Jackson and Coop, 2000), reversion
to anthelmintic sensitivity is unlikely to occur once populations
are measured as anthelmintic resistant by conventional means
such as the faecal egg count reduction test (FECRT). For these rea-
sons, more sustainable methods of nematode control are now
required, these being based on a requirement to treat animals pre-
disposed to larger burdens to prevent clinical disease, balanced
with a need to reduce treatment frequency to preserve anthelmin-
tic efﬁcacy. In the last decade, regulations in the European Union
(EU) require that anthelmintics be classiﬁed as prescription-only
drugs. Currently, the legislation is interpreted differently across
the EU, with strictest implementation in Denmark where anthel-
mintic administration is based on diagnostic evidence of infection
(Nielsen et al., 2012). Deployment of such diagnostic-based control
strategies requires that robust and practical support tools are avail-
able. Coprological analysis for nematode eggs is central to this
strategy, but this method is incapable of discriminating pre-patent
infection. With the extended pre-patent period of several
strongyle species, there is a requirement for diagnostic tests that
detect and quantify levels of immature stages. A number of
antigens are under investigation as diagnostic markers for
detecting pre-patent cyathostomin (McWilliam et al., 2010) and
S. vulgaris (Andersen et al., 2013a) infections. Until these are avail-
able, FEC-directed treatments will need to be balanced with
anthelmintics applied strategically to target pathogenic larvae
(Matthews, 2008).2. Anthelmintic resistance
Interval-based treatment programmes, which have been used
extensively in the equine industry, will be expected to select resis-
tance alleles within nematode populations (Kaplan and Nielsen,
2010). Resistance to the earlier registered anthelmintics, the benz-
imidazoles and the tetrahydropyrimidines, has been reported
many times in cyathostomin populations across the world, and
resistance to both of these classes in single populations is a com-
mon observation in ﬁeld studies (Kaplan et al., 2004; Traversa
et al., 2009; Traversa et al., 2012). As fenbendazole resistance in
cyathostomins is virtually ubiquitous in many regions (Osterman
Lind et al., 2007; Traversa et al., 2012; Lester et al., 2013b; Relf
et al., 2014; Stratford et al., 2014b), this anthelmintic should not
be recommended for use in control of these infections in these
areas. Perhaps surprisingly, despite the substantial reliance on
ivermectin and moxidectin for equine nematode control in the last
30 years, resistance, measured as a reduction in FEC of less than
90–95% at 14–17 days after treatment, has been reported infre-
quently. Nevertheless, there have now been several reports of
reduced strongyle egg ERP after ivermectin or moxidectin adminis-
tration in a number of countries (von Samson-Himmelstjerna et al.,
2007; Molento et al., 2008; Lyons et al., 2009; Lyons et al., 2010;
Rossano et al., 2010; Lyons et al., 2011; Lyons and Tolliver, 2013;
Canever et al., 2013; Relf et al., 2014). Reduced ERP is believed to
provide an early indicator of a shift in a nematode population’s
sensitivity towards resistance (Sangster, 2001) and so this provides
a warning as to the likely long-term effect of macrocyclic lactone
compounds in horses.
Ivermectin resistance measured as low FEC reduction after
treatment has been reported with regularity in P. equorum popula-
tions (Boersema et al., 2002; Hearn and Peregrine, 2003; Stoneham
and Coles, 2006; Craig et al., 2007; Schougaard and Nielsen, 2007;
von Samson-Himmelstjerna et al., 2007; Reinemeyer, 2012). These
ﬁndings are unsurprising given the excessively frequent use of
ivermectin in foals on stud farms. Control of ivermectin resistant
P. equorum populations can theoretically be achieved using
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ivermectin resistant P. equorum populations have been shown to
exhibit resistance to tetrahydropyrimidines as well (Reinemeyer,
2012). Benzimidazole resistance in P. equorum has not yet been
published in the literature, but there is now anecdotal evidence
of a lack of efﬁcacy of this compound on stud farms in the UK
(Matthews, unpublished observations). These reports highlight the
threat of multi-class resistance in this nematode species and is a
major concern for stud farmers given the potential pathogenicity
of this parasite in foals.
All of the aforementioned issues highlight the risk of multi-class
resistance in equine nematode populations and the complexity of
patterns of infection and resistance that will need to be dealt with
in the ﬁeld. As anthelmintic choice now needs to be more evidence
based, the tools that inform on levels of infection and anthelmintic
efﬁcacy need to be robust.3. Tools for monitoring infection and detecting anthelmintic
resistance
3.1. Faecal egg count analysis
The FEC test is a relatively easy method in which the number of
strongyle and P. equorum eggs in equine faeces can be estimated at
a speciﬁc point in time. A number of FEC techniques exist and these
differ in sensitivity, speed of generation of results and the level of
expertise required to perform the test. In all cases, it is essential
that good practice be followed at each stage: from collection of
samples at the yard or farm, to processing and analysis in the lab-
oratory. In this way, examination of representative samples should
provide a reasonable estimation of the level of egg excretion in
each individual. Several studies, published in the last few years,
have highlighted several factors that affect the accuracy of FEC
analysis in horses and how these factors might impact the outcome
of efﬁcacy testing (Nielsen et al., 2010; Vidyashankar et al., 2012;
Lester and Matthews, 2014). Generally, FEC test output is affected
by differences in egg shedding at individual level (Denwood et al.,
2012), the over-dispersion of nematode eggs in faeces (Lester et al.,
2012), the non-uniform distribution of nematode eggs in suspen-
sion (Vidyashankar et al., 2012), the type of FEC method used
(Lester and Matthews, 2014) and by sampling and storage prac-
tices (Nielsen et al., 2010). A number of recommendations have
come out of these studies and are as follows. Studies on strongyle
egg hatching and larval development suggest that faecal samples
should be collected as fresh as possible (at most < within 12 h),
and then refrigerated (Nielsen et al., 2010). Nematode eggs are
unevenly distributed throughout equine faeces and it is therefore
important to ensure that several samples are taken from different
parts of the dung heap at sampling and that thorough mixing be
performed before taking further sub-samples for counting
(Denwood et al., 2012; Lester and Matthews, 2014). If samples
need to be stored for any period, anaerobic storage is advised
(Nielsen et al., 2010). As horses tend to have lower egg per gram
values than other species, such as sheep, FEC methods with a
higher sensitivity should be used. For example, when egg detection
limits are higher (for example, when using the modiﬁed McMaster
method with a 25 or 50 multiplication factor), the test will not be
sufﬁciently sensitive to changes in egg abundance below or around
the detection limit and, as a consequence, false negative results are
more likely (Lester and Matthews, 2014). This is particularly rele-
vant when assessing anthelmintic efﬁcacy, as post treatment
counts are more likely to be low. A test with a low egg detection
limit (i.e. one with a lower/no multiplication factor for conversion
of number of eggs) is more sensitive and will provide a more accu-
rate estimation of eggs per gram.3.2. Measuring anthelmintic resistance
In evidence-based parasite control programmes, anthelmintic
efﬁcacy should be tested on a regular basis. The FECRT is the com-
monest method for assessing efﬁcacy in vivo and for monitoring
prevalence of anthelmintic resistance in the ﬁeld. The most widely
published method is that recommended by the World Association
for the Advancement of Veterinary Parasitology (WAAVP; Coles
et al., 1992). This method calculates efﬁcacy based on the arithme-
tic mean reduction in FEC observed between Day 0 and Days 14–17
after treatment. The WAAVP guidelines were originally designed
for small ruminants and there exist no universally agreed cut-off
limits for determining efﬁcacy for anthelmintic classes in horses;
these values vary among published reports. This absence of a unan-
imous deﬁnition for equine FECRT methodology makes it challeng-
ing to draw comparisons between studies. Moreover, inherent
variability observed in equine FEC datasets (associated with the
factors outlined above) can complicate the outcome the test
(Denwood et al., 2010; Lester et al., 2013b; Stratford et al.,
2014b). Recently published studies have attempted to deﬁne more
accurate methods for calculating anthelmintic efﬁcacy in horses
(Vidyashankar et al., 2007; Kaplan and Nielsen, 2010;
Vidyashankar et al., 2012; Lester et al., 2013b; Relf et al., 2014;
Stratford et al., 2014b). In these, an arithmetic mean FECR of
>95% was set for macrocyclic lactone anthelmintics, whilst a
threshold of >90% was set for efﬁcacy for benzimidazole and tetra-
hydropyrimidine anthelmintics. To give an indication of the data
range inherent in these datasets, 95% lower conﬁdence limits
(LCL) were calculated (Vidyashankar et al., 2007; Lester et al.,
2013b; Relf et al., 2014). In terms of the 95% LCL selected for clas-
sifying resistance, this varied depending on the class of anthelmin-
tic tested with the percentage reduction threshold used for
classifying resistance to macrocyclic lactones set at 90% and, for
benzimidazoles and tetrahydropyrimidines, 80%. These cut-offs
have been selected to reﬂect original efﬁcacy levels reported in
anthelmintic-sensitive strongyle populations soon after the prod-
ucts were registered for use in horses (Cornwell and Jones, 1969;
Colglazier et al., 1977; Xiao et al., 1994). Maximum likelihood
models, based on the negative binomial distribution for estimating
FEC reduction (Torgerson et al., 2005), and Markov Chain Monte
Carlo methods (Denwood et al., 2010) have also been suggested
to account for the highly aggregated distribution inherent in
equine FEC data. A limitation in these methodologies is that they
require the ability to use advanced statistical programmes such
as R. Recently, though, a web-interface has been developed to
enable researchers to enter FEC datasets online, together with
the detection limit of the FEC method used to generate the counts.
This interface estimates the percentage of FEC reduction using
Bayesian hierarchical models via Markov Chain Monte Carlo sam-
pling (http://www.math.uzh.ch/as/index.php?id=calc, Torgerson
et al., 2014) and now provides access for the layperson to more
robust methods of computing efﬁcacy.
Similar to the issues encountered with the FECRT, there are no
well-deﬁned guidelines on how to calculate and interpret stron-
gyle ERP datasets in horses. In the main, two methods have been
used: one, deﬁned as the week of the ﬁrst positive strongyle FEC
after anthelmintic administration (Dudeney et al., 2008; Lyons
et al., 2008; Molento et al., 2008), and the other, deﬁned when
the group arithmetic mean FEC exceeds 10% of the group arithme-
tic mean FEC at Day 0 (Borgsteede et al., 1993; Jacobs et al., 1995;
Boersema et al., 1996; Mercier et al., 2001; Tarigo-Martinie et al.,
2001; von Samson-Himmelstjerna et al., 2007; Larsen et al.,
2011). The second method gives a more conservative estimate of
egg reappearance with respect to the level and spread of the FEC
data sampled prior to treatment and so gives a more accurate mea-
sure a population’s sensitivity to anthelmintic. More research is
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standardized so that analysis can be made between studies.3.3. Measuring pre-patent infections
Because of the pathogenicity of immature cyathostomin and S.
vulgaris larvae, diagnostic tests that detect and quantify levels of
these stages are required. A number of antigens are under investi-
gation as diagnostic markers for detecting pre-patent cyathosto-
min (Dowdall et al., 2002; Dowdall et al., 2004; McWilliam et al.,
2010) and S. vulgaris (Andersen et al., 2013a) infections. A cyatho-
stomin ELISA is being developed, which is based on measurement
of levels of serum IgG(T) speciﬁc to two antigens present in early
and late third stage larvae and developing fourth stage larvae
(Dowdall et al., 2002; Dowdall et al., 2004; McWilliam et al.,
2010). IgG(T) levels speciﬁc to these antigens have been shown
to increase to 20 and 25 kDa complexes in native extracts of larvae
(Dowdall et al., 2004) and to recombinant versions of proteins
present within these complexes (McWilliam et al., 2010) within
5–6 weeks of a primary cyathostomin infection. The recombinant
proteins have now been evaluated in an indirect ELISA format as
a cocktail of antigens spanning nine common cyathostomin species
and this cocktail is currently under assessment as to its utility in
informing on cyathostomin encysted larval burden. A number of
S. vulgaris antigens that are targets of antibody responses in
infected horses have been described, but most of these have not
been well characterised in terms of their speciﬁcity or their predic-
tive value in informing on larval burdens (Andersen et al., 2013b).
Recently, a S. vulgaris antigen, SvSXP, was identiﬁed as a possible
diagnostic marker (Andersen et al., 2013a). Similar to the cyatho-
stomin proteins described above, this antigen was identiﬁed by
immunoscreening a larval stage complimentary DNA library using
rabbit serum raised against adult worm excretory/secretory prod-
ucts. Immunoblotting experiments and preliminary ELISA analysis
indicate that serum IgG(T) responses to this protein have potential
as diagnostic markers of pre-patent infection (Andersen et al.,
2013a). Until these tests are developed further and become
commercially available, FEC-directed treatments will need to be
balanced with anthelmintic applied strategically to target patho-
genic larvae for both types of infections.4. Sustainable control
Clearly, there is a real need for better management of equine
nematodes, with improvement in anthelmintic use decisions the
cornerstone of improved programmes that aim to avoid unneces-
sary or ineffective treatments. The practice of FEC-directed treat-
ments can be highly effective in reducing anthelmintic
administration frequency in horses because egg excretion is highly
over dispersed amongst individuals (Relf et al., 2013; Lester et al.,
2013b). A commonly quoted dogma is that 20% of the equine pop-
ulation excretes 80% of the parasite burden into the environment
(Matthews, 2008) and recent studies have demonstrated that, in
well-managed populations, the actual percentage of horses respon-
sible for 80% excretion is lower than 20% (Relf et al., 2013; Lester
et al., 2013b). In FEC-directed treatment programmes, high shed-
ders (for example, horses excreting more than 200 eggs per gram
[EPG] in faeces) are targeted with anthelmintics, whilst those iden-
tiﬁed as shedding negligible to moderate levels of eggs are left
untreated (Duncan and Love, 1991). In this way, anthelmintic
treatments are reduced at the same time as pasture contamination
is lowered. It is assumed that nematodes in untreated horses will
act as a source of ‘refugia’ (van Wyk, 2001) and that the progeny
of these will act to dilute resistant alleles in offspring derived from
worms that survive in horses administered with anthelmintic.There have been no quantitative studies that substantiate these
principles in horses; nevertheless, the delivery of fewer anthelmin-
tic treatments over time and the requirement to monitor nematode
egg excretion proﬁles within populations provides the basis for
more responsible control programmes. Due to the long pre-patent
period of a number of strongyle worm species and, because severe
disease can be caused by the larval stages of some of these species,
FEC-directed treatments need to be balanced with a requirement
to treat stages of nematodes that are undetectable by FEC analysis.
In the absence of diagnostic tests that allow estimation of imma-
ture larvae, treatments with larvicidal anthelmintics (i.e. moxidec-
tin) are recommended at speciﬁc times of year (Matthews, 2008;
Hertzberg et al., 2014). The future availability of diagnostics that
allow estimation of burden of pre-patent stages will enable speciﬁc
targeting of individuals with larvicidal anthelmintics, as these tests
can be used to identify horses estimated to harbour above a certain
threshold of larval numbers. Such targeting should facilitate fur-
ther reductions in anthelmintic usage at those times of year when
larvicidal treatments are indicated.
Targeted treatment programmes have had variable uptake
across regions and countries and between different types of man-
agement systems, with poorer uptake on Thoroughbred stud farms
(Relf et al., 2013; Robert et al., 2014) and better uptake by the lei-
sure horse sector (Lester et al., 2013a; Stratford et al., 2014a).
Where targeted treatment programmes have been followed, large
reductions in anthelmintic use have resulted (Lester et al.,
2013a). The challenge now lies in disseminating these programmes
further. Recent data from the USA indicates that stud farm owners,
for example, are only willing to change to more evidence-based
control measures if they are assured that such approaches would
prevent anthelmintic resistance and decrease health risks signiﬁ-
cantly (Robert et al., 2014). Further research is required to provide
such evidence, particularly as one recent study indicated an appar-
ent increase in the prevalence of S. vulgaris infections on farms
where reduced anthelmintic treatment intensity had been imple-
mented over several years (Nielsen et al., 2012).
Despite a gradual move towards more evidence-based anthel-
mintic use, the prevalence of resistance in some populations is very
high, with resistance reported to every class available (Trawford
and Burden, 2012). Thus, it is imperative that, alongside imple-
mentation of these strategies, other methods of control are used
so that there is not sole reliance on the use of anthelmintics to
break the nematode transmission cycle. One option is to reduce
contamination of grazing by removal of faeces from pasture. In
1986, Herd (Herd, 1986) demonstrated that pasture management,
via the removal of faeces twice a week alone, was more effective
than anthelmintic therapy in reducing pasture levels of strongyle
larvae. This study was performed before the widespread use of
moxidectin, which has a prolonged egg suppressive effect. More
recently, studies undertaken on a UK donkey sanctuary conﬁrmed
the effectiveness of faecal removal from pasture in reducing nem-
atode transmission (Corbett et al., 2014). These studies conﬁrmed
that twice-weekly removal of faeces from pasture signiﬁcantly
reduced the number of strongyle eggs shed in faeces from groups
of co-grazed donkeys, thus verifying this practice was a useful
management tool to further reduce use of anthelmintics. Faecal
removal is recommended at intervals frequent enough to prevent
third stage larvae developing and translating onto pasture and this
interval has been measured as approximately two weeks in warm
temperate conditions (Ramsey et al., 2004), but development may
be more rapid in tropical and sub-tropical regions. Alternated graz-
ing with ruminants will also decrease levels of strongyle contami-
nation on pasture over time, but care must be taken to monitor for
helminths that can be transmitted between sheep and horses (in
particular, F. hepatica). Further research is required in these areas
to provide quantitative evidence on the utility of these control
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recommendations.
5. Final conclusions
The lack of benzimidazole and tetrahydropyrimidine efﬁcacy
measured in equine nematode populations across the world, along
with clear indications of emerging resistance against ivermectin
and moxidectin, emphasises the need for fundamental changes in
the way that nematodes are managed in horses. The macrocyclic
lactone anthelmintics have the major market share globally and
until recently, serious consideration had not been given to protect-
ing efﬁcacy of these compounds by implementing control pro-
grammes that use these medicines in a more targeted manner.
Although targeted programmes are being used in some regions,
the advantages of these programmes need further dissemination
to ensure further uptake. Many horses are still subjected to regular
blanket anthelmintic treatments with no attention paid to efﬁcacy
and a lack of uptake of evidence-based strategies may be due to the
perceived complexity involved in integrating these methods in
practice. It is essential that barriers be broken down so that those
involved in prescribing and administering anthelmintics have con-
ﬁdence in delivering evidence-based protocols. This requires that
stakeholders have easy access to up-to-date knowledge, as well
as to robust diagnostic tests required to support decision-making.
The gap between research ﬁndings and implementation at farm
level is a continuing challenge for scientists working in equine par-
asitology. One piece of evidence to start reducing this gap is that
initial feedback from horse owners indicates that by using targeted
treatment strategies, considerably fewer anthelmintic treatments
are applied (Lester et al., 2013a; Hertzberg et al., 2014). Further-
more, that this can lead to substantial ﬁnancial savings (Lester
et al., 2013a). There is still a requirement for better tools that will
inform evidence-based parasite control, but new tests are on the
horizon and these will need to be priced and marketed properly
to ensure that they are used across the equine industry. By moving
to evidence-based parasite management built on best practice (i.e.
limiting use of anthelmintics and ensuring correct dose rates),
combined with targeted grazing management and exploiting avail-
able diagnostic tools, the efﬁcacy of the currently effective anthel-
mintics might be prolonged until new chemotherapeutics are
discovered. This is paramount because reversion to anthelmintic
susceptibility, in all probability, will not occur in nematode popu-
lations once they have become resistant.
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